Yahoo Web Search

Search results

1. www.vrtx.comVertex Pharmaceuticals | Home

   www.vrtx.com

   • Cached

   Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.

   • Our Company

     Vertex Pharmaceuticals strikes at the core of serious...

   • Our Science

     Vertex Forward: Illustrating Our Scientific Strategy A...

   • Medicines

     Vertex’s Inclusion, Diversity and Equity Priorities Our...

   • Patients

     At Vertex Pharmaceuticals, our commitment to patients is...

   • Responsibility

     At Vertex, giving back includes providing opportunities to...

   • Careers

     Recruitment & Staffing Agencies: Vertex Pharmaceuticals does...

   • News

     The Investor Relations website contains information about...

   • Investors

     Contacting Vertex's Transfer Agent. Communication regarding...

2. Videos

   • 

     1:04

     youtube.com

     Why Join Vertex Pharmaceuticals | Vertex Pharmaceuticals

     29 Apr 2021

     1.1K views

   • 

     3:46

     youtube.com

     Vertex Pharmaceuticals Virtual Lab Tour | Vertex Pharmaceuticals

     10 Apr 2020

     232.1K views

   • 

     3:31

     youtube.com

     Vertex Forward: Diving Into Type 1 Diabetes | Vertex Pharmaceuticals

     19 Jul 2023

     3.7K views

   View all

3. Top stories

   • Business Insider

     Maintaining Hold Rating on Vertex Pharmaceuticals Amidst LSR Trial Uncertainties

     Morgan Stanley analyst Terence Flynn maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price

     12 hours ago

   • 

     MarketWatch

     Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains

     2 days ago

   • YAHOO!Finance

     Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing

     In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $465.08, denoting a +0.48% change from the preceding trading day.

     1 day ago

   • BioPharma Dive

     5 FDA decisions to watch in the fourth quarter

     Over the next three months, the agency could approve a rival to a fast-selling Pfizer heart drug, a much-debated lung cancer medicine and an addition to Vertex's dominant cystic fibrosis business.

     18 hours ago

   • YAHOO!Finance

     Vertex Pharmaceuticals presents vanzacaftor/tezacaftor/deutivacaftor data

     5 days ago

   View all

4. en.wikipedia.org › wiki › Vertex_PharmaceuticalsVertex Pharmaceuticals - Wikipedia

   en.wikipedia.org › wiki › Vertex_Pharmaceuticals

   • Cached

   Vertex Pharmaceuticals is an American biopharmaceutical company that develops drugs for serious diseases, such as cystic fibrosis and hepatitis C. Learn about its origins, acquisitions, collaborations, and medicines, including Kalydeco, Orkambi, and Trikafta.

5. www.vrtx.com › our-companyVertex Pharmaceuticals | Our Company

   www.vrtx.com › our-company

   • Cached

   Vertex is a biopharmaceutical company that creates transformative medicines for people with serious diseases. Learn about their mission, values, culture, R&D and recognition.

6. www.vrtx.com › our-science › pipelineVertex Pharmaceuticals | Our Science | R&D Pipeline

   www.vrtx.com › our-science › pipeline

   • Cached

   Vertex is a biotechnology company that develops innovative medicines for cystic fibrosis, pain, sickle cell disease, beta thalassemia and other serious conditions. Learn about its pipeline programs, phases, technologies and outcomes.

7. finance.yahoo.com › quote › VRTXVertex Pharmaceuticals Incorporated (VRTX) - Yahoo Finance

   finance.yahoo.com › quote › VRTX

   • Cached

   Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

8. news.vrtx.com › news-releases › news-release-detailsPress Release - Vertex Pharmaceuticals Newsroom

   news.vrtx.com › news-releases › news-release-details

   • Cached

   Dec 8, 2023 · CASGEVY is a CRISPR/Cas9 genome-edited cell therapy for sickle cell disease (SCD) that offers the potential of a functional cure by reducing vaso-occlusive crises. Vertex leads global development and commercialization of CASGEVY, with support from CRISPR Therapeutics.

9. news.vrtx.com › news-releases › news-release-detailsPress Release - Vertex Pharmaceuticals Newsroom

   news.vrtx.com › news-releases › news-release-details

   • Cached

   Jun 21, 2024 · Vertex presents positive results from a Phase 1/2 study of VX-880, a stem cell-derived islet cell therapy for type 1 diabetes. VX-880 shows islet cell engraftment, glucose-responsive insulin production, and elimination of severe hypoglycemic events in patients.